Plasma B Cell Antibody Discovery Workflow

Berkeley Lights, Inc. offers a plasma B cell antibody discovery workflow for use on the Beacon Optofluidic Platform. The workflow reduces screening and assay time to 24 hours—within the timeframe when plasma B cells are still viable. In addition, it alleviates immunogenicity and functionality concerns by using naturally produced antibodies that can be assessed within the platform. Use of this technology for antibody discovery greatly increases the chances of finding the novel antibody by screening a higher percentage of the immune repertoire.